Skip to product information
1 of 1
Regular price £42.99 GBP
Regular price Sale price £42.99 GBP
Sale Sold out
Free UK Shipping

Freshly Printed - allow 10 days lead

The Movement Disorders Prescriber's Guide to Parkinson's Disease

Essential and concise clinical reference guide for practitioners who prescribe for patients with Parkinson's disease and movement disorders.

K. Ray Chaudhuri (Author), Peter Jenner (Author), Valentina Leta (Author), Shelley Jones (Author), Iro Boura (Author)

9781009222617, Cambridge University Press

Paperback / softback, published 27 February 2025

600 pages
19.1 x 11.9 x 3.2 cm, 0.56 kg

This concise, yet authoritative, clinical reference guide fulfils the needs of diverse clinicians, pharmacists and allied health professionals prescribing for Parkinson's disease and movement disorders in contemporary clinical practice. With chapters on newly approved drugs and their effects on motor and non-motor symptoms, information is also given on their use in particular populations including the elderly and patients with cognitive impairment. Each chapter includes pharmacological/biochemical rationale for drug use, a general guide to therapeutic use, pharmacokinetics, interaction profile, adverse effects, dosing and use, special population considerations, costs and value for money considerations, clinical vignette, a summary overview, and suggested reading. Ordered alphabetically and perfect for quick reference use, the guide is practical and essential for all prescribers with responsibility for patients with Parkinson's disease, including neurologists, geriatricians, internists, neurosurgeons, psychiatrists, family physicians, pharmacists as well as allied health professionals and resident, fellow, and student trainees in all related medical fields.

Foreword from Professor Chaudhuri
Introduction
Amantadine
Amitriptyline
Apomorphine Infusion
Apomorphine Injection
Apomorphine Sublingual
Botulinum
Citalopram
Clonazepam
Clozapine
Desimpramine
Domperidone
Donepezil
Droxidopa
Entacapone
Fludrocortisone
Glycopyrrolate
Istradefylline
Levodopa benserazide
Levodopa carbidopa
Levodopa carbidopa entacapone intestinal gel
Levodopa carbidopa intestinal gel
Levodopa inhaled
Lubipristone
Macrogol
Melatonin
Memantine
Midodrine
Mirabegron
Mirtazepine
Modafanil
Naltrexone
Nortriptyline
Opicapone
Oxybutynin
Piribedil
Pramipexole
Pimavenserin
Quetiapine
Rasagiline
Rivastigmine
Ropinirole
Rotigotine
Safinamide
Selegiline
Sildenafil
Solifenacin
Tolcapone
Tolterodine
Trihexyphenidyl
Venlafaxine
Zonisamide
Abbreviations.

Subject Areas: Neurology & clinical neurophysiology [MJN]

View full details